Takeaway: We're expecting mgmt to fall on its sword, but the buy side may be too. The latter is a mild risk, but not enough to consider covering.
Let us know if you have questions, or would like to discuss further.
Hesham Shaaban, CFA
YELP: The New Major Red Flag (1Q15)
04/30/15 08:53 AM EDT
The total percentage of successful long and short trading signals since the inception of Real-Time Alerts in August of 2008.
Takeaway: Our visit to PENN’s new Plainridge casino has only enhanced our already high enthusiasm for its contribution to PENN’s equity value
Following Friday’s site visit to PENN’s new slot facility in Plainville, we’re raising our win per day per slot assumption to $500 from $400. Terrific highway access, a lower gaming tax rate and garage parking provide a competitive advantage in what seems to be a deeper market than the consensus view. Our 2015 and 2016 estimates are materially above the Street for EBITDA and EPS. Most importantly, we think PENN should generate an ROI of 28% on Plainridge, much higher than the Street anticipates.
After raising the win per slot per day assumption from $400 to $500 going forward ($525 for Q3), our Plainridge EBITDA run rate forecast rises to $69 million. PENN owns the real estate in Plainville so EBITDA=EBITDAR.
On Friday, we attended PENN’s analyst day at the Plainridge Casino in Massachusetts. We struggled to find any negative takeaways. The property opened very strong in late June, and the strength continued in July. Here are some takeaways:
PENN has a done a nice job with the new casino (clean bathrooms and ample parking) and it’s showing in the early results. We believe Street estimates for PENN will need to move higher as early as Q3 and certainly for 2016, due in part to the strength of Plainridge. We’re now projecting $340 and $383 million in company EBITDA for 2015 and 2016. Our EPS estimates are $0.66 and $1.10 for 2015 and 2016, respectively - 12% and 16% above the Street, respectively.
Takeaway: U.S. cash equity volume is vaulting higher by +16% Y/Y with U.S. equity option volume not far behind at +10 Y/Y.
We recently presented our investment thesis on the Exchanges. To summarize,
We think CME has $5 per share in earnings power in the out year and the stock will revisit near $140. As outlined in our presentation deck and replay below, a CME long position can also be paired with a short ICE position, with favorable fundamental exposures on each side of the trade.
Separately, recent IPO Virtu (VIRT) is being valued incorrectly by the market. Our main qualm is that the company takes intraday prop risk, but has no tangible equity capital to cover any potential trading losses. Shares of VIRT are currently on our Best Ideas list as a short with a fair value in the mid-teens (30-40% downside).
Hedgeye Exchange Black Book Replay HERE
Hedgeye Exchanges Black Book Materials HERE
Weekly Activity Wrap Up: U.S. equity options are putting up the best quarter-over-quarter growth so far. The running quarter-to-date average for options is currently 17.3 million contracts, up +10% year-over-year and better by 15% sequentially from 2Q15. Futures activity hit 14.2 million contracts this week, lower than the running 3Q15 average of 17.2 million contracts quarter-to-date, which is down -5% year-over-year. U.S. cash equity trading is showing the largest year-over-year growth, running higher by +16% Y/Y thus far in the new 3rd quarter.
U.S. Cash Equity Detail: U.S. cash equity trading finished the week at 6.6 billion shares traded which is also blending to a 6.6 billion daily average thus far for the 3rd quarter of 2015. This is +16% year-over-year growth for U.S. stock activity. The market share battle for volume is mixed, with the New York Stock Exchange/ICE standing pat at 24% market share and NASDAQ continuing to cede share to competitors. NASDAQ thus far this quarter has taken just 18% share of all U.S. stock trading, down 200 basis points year-over-year or a -6% decline.
U.S. Options Detail: U.S. options activity continues to churn higher with 18.0 million contracts traded this week which is blending 3Q15 activity to 17.3 million contracts per day, up +10% year-over-year. The market share battle amongst venues continues to be one of losses at both the NYSE/ICE and NASDAQ. NYSE has lost 400 basis points of share year-over-year settling at just 18% of options trading currently. NASDAQ has also shed 400 basis points of share, good for a -16% loss from last year as ISE/Deutsche Boerse and BATS mop up volume and share.
U.S. Futures Detail: CME Group volume has been relatively low the last couple weeks. In the most recent 5-day period ending July 23rd, activity levels were 10.5 million contracts at the big futures exchange. 3Q15 volumes are blending to a 12.9 million average level which is a -4% year-over-year decline. CME open interest continues in strong fashion with the latest count this week showing 100.1 million contracts pending, good for +17% year-over-year growth. Activity levels on the futures side at ICE hit 3.7 million contracts this week, with 3Q15 blending to a 4.3 million daily average. That amounts to a -6% year-over-year decline. ICE open interest this week tallied 72.6 million contracts, continuing a -4% year-over-year contraction.
Monthly Historical View: Monthly activity levels give a broader perspective of exchange based trends. Largely, volatility levels are just starting to rise after drastic compression this cycle. Thus as the VIX, MOVE, and FX Vol starts to normalize, we expect all marketplaces to experience higher activity levels.
Sector Revenue Exposure: The exchange sector has broadly diversified its revenue exposure over 10 years as public entities with varying top line sensitivity to the enclosed trading volume data. The table below highlights how trading volumes will flow through the various operating models at NASDAQ, CME Group, ICE, and Virtu:
Please let us know of any questions,
Jonathan Casteleyn, CFA, CMT
Joshua Steiner, CFA
Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.